Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114827) titled 'Clinical study of serine protease inhibitors in high-risk bleeding patients undergoing maintenance hemodialysis' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The peoples hospital of xuancheng city
Condition:
Chronic Kidney Disease Stage 5
Intervention:
control group:sodium citrate
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-28
Target Sample Size: control group:30;Observation group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=276085
Published by HT Digital Conten...